(Total Views: 837)
Posted On: 03/04/2022 1:29:13 PM
Post# of 148884
A really good read addressing inflammation and its impact.
When you read about macrophages and resolution of inflammation, think Leronlimab.
https://apple.news/AnFyRr0dYThinV0dx9n7tQw
https://www.nationalgeographic.com/science/ar...f-diseases
The end of inflammation? New approach could treat dozens of diseases.
Cancer, aging, and severe COVID-19 have all been linked to damage from inflammation. Now scientists are flipping their focus to find new drugs that may revolutionize treatments.
“ Because they’re so abundant during inflammation, macrophages have traditionally been thought of as pro-inflammatory cells, says Gerhard Krönke, an immunologist and rheumatologist at the University of Erlangen-Nürnberg. “But a paradigm shift in the last decade or so suggests that macrophages are pivotal players in the resolution of inflammation.”
Gilroy agrees, calling macrophages “linchpin cells at the juxtaposition of inflammation and resolution: It can go one way if we’re healthy and the other way if we’re not.””
When you read about macrophages and resolution of inflammation, think Leronlimab.
https://apple.news/AnFyRr0dYThinV0dx9n7tQw
https://www.nationalgeographic.com/science/ar...f-diseases
The end of inflammation? New approach could treat dozens of diseases.
Cancer, aging, and severe COVID-19 have all been linked to damage from inflammation. Now scientists are flipping their focus to find new drugs that may revolutionize treatments.
“ Because they’re so abundant during inflammation, macrophages have traditionally been thought of as pro-inflammatory cells, says Gerhard Krönke, an immunologist and rheumatologist at the University of Erlangen-Nürnberg. “But a paradigm shift in the last decade or so suggests that macrophages are pivotal players in the resolution of inflammation.”
Gilroy agrees, calling macrophages “linchpin cells at the juxtaposition of inflammation and resolution: It can go one way if we’re healthy and the other way if we’re not.””
(10)
(0)Scroll down for more posts ▼
